Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies-Reference-Cited by-全球学者库

登录注册会员服务联系我们

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

Published:2023-11-15 Issue:22 Volume:133 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Chong Stephen Jun Fei,Zhu Fen,Dashevsky Olga,Mizuno Rin,Lai Jolin X.H.,Hackett Liam^ORCID,Ryan Christine E.^ORCID,Collins Mary C.^ORCID,Iorgulescu J. Bryan^ORCID,Guièze Romain,Penailillo Johany^ORCID,Carrasco Ruben,Hwang Yeonjoo C.^ORCID,Muñoz Denise P.^ORCID,Bouhaddou Mehdi,Lim Yaw Chyn,Wu Catherine J.,Allan John N.,Furman Richard R.^ORCID,Goh Boon Cher,Pervaiz Shazib,Coppé Jean-Philippe^ORCID,Mitsiades Constantine S.^ORCID,Davids Matthew S.^ORCID

Funder

Simeon J. Fortin Charitable Foundation

Leukemia and Lymphoma Society

National Institutes of Health

Dana-Farber Cancer Institute Lymphoma Pilot Grant

Dana-Farber Cancer Institute Medical Oncology Grant Program

Novartis Drug Discovery and Translational Research Program

Pan-Mass Challenge Team FLAMES funding

Conquer Cancer Foundation/Sontag Foundation

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/170169/files/pdf

Reference58 articles.

1. Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia

2. Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

3. Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

4. Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

5. Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Resistance in Chronic Lymphocytic Leukemia—Maybe Less Is More?;Clinical Cancer Research;2023-12-06

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3